SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-018236
Filing Date
2022-09-08
Accepted
2022-09-08 16:01:39
Documents
81
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-K meip-20220630.htm   iXBRL 10-K 2926265
2 EX-23.1 meip-ex23_1.htm EX-23.1 3829
3 EX-31.1 meip-ex31_1.htm EX-31.1 21474
4 EX-31.2 meip-ex31_2.htm EX-31.2 21445
5 EX-32.1 meip-ex32_1.htm EX-32.1 17551
6 GRAPHIC img103136815_0.jpg GRAPHIC 132628
  Complete submission text file 0000950170-22-018236.txt   11515185

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT meip-20220630_def.xml EX-101.DEF 344622
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20220630_pre.xml EX-101.PRE 459288
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20220630.xsd EX-101.SCH 68774
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT meip-20220630_cal.xml EX-101.CAL 60003
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20220630_lab.xml EX-101.LAB 545979
75 EXTRACTED XBRL INSTANCE DOCUMENT meip-20220630_htm.xml XML 2248570
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-50484 | Film No.: 221233840
SIC: 2834 Pharmaceutical Preparations